Triglimisave 1 HS+ Tablet SR
Marketer
Eris Lifesciences Ltd
Salt Composition
Glimepiride (1mg) + Metformin (1000mg) + Pioglitazone (15mg)
Overview Triglimisave 1 HS+ Tablet SR
Glycemicontrol HS+ is a dual-action formulation designed to manage blood glucose levels. Used in conjunction with a healthy diet and regular exercise, it enhances glycemic control in adult patients with type 2 diabetes. This medication promotes efficient insulin utilization, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Glycemicontrol HS+. Ingestion with food is recommended to minimize gastrointestinal discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose. Overdosage can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before commencing treatment. Kidney function tests will be assessed by your physician before treatment begins. Limit alcohol consumption as it may exacerbate certain adverse effects.
Uses of Triglimisave 1 HS+ Tablet SR
Managing Type 2 diabetes
Major Benefits of Triglimisave 1 HS+ Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Triglimisave 1 HS+ Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with food.
Common Side effects of Triglimisave 1 HS+ Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triglimisave 1 HS+ Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Triglimisave 1 HS+ Tablet SR. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.
How Triglimisave 1 HS+ Tablet SR works:
Triglimisave 1 HS+ SR tablets contain a triple-action formulation for diabetes management: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to enhance blood glucose regulation when monotherapy or dual-agent regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and augmenting insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Triglimisave 1 HS+ Tablet SR and alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Triglimisave 1 HS+ Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Triglimisave 1 HS+ Tablet may pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk, possibly causing harm to the nursing child.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms manifest.
KidneyCAUTION
Patients with kidney impairment should use Triglimisave 1 HS+ Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular monitoring of kidney function is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Triglimisave 1 HS+ Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. Triglimisave 1 HS+ Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Triglimisave 1 HS+ Tablet SR :
Should you forget a Triglimisave 1 HS+ Tablet SR dose, take it immediately if you remember. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Triglimisave 1 HS+ Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently